Life Raft Group

Information about Life Raft Group

Published on August 9, 2007

Author: Richie

Source: authorstream.com

Content

2006 CTOS:  2006 CTOS Changing Role of Patient Organizations In Cancer Research Announcement:  Announcement A cure for all cancers has just been discovered! GO HOME !:  GO HOME ! Just kidding:  Just kidding On the other hand, One has to wonder Slide5:  For patients with GIST (Gastrointestinal Stromal Tumor) Life Raft Group Our MissionIs Survival:  Our Mission Is Survival Keeping GIST Patients Alive By Ensuring:  Keeping GIST Patients Alive By Ensuring That no one dies because they cannot access treatment That no one dies because of their ignorance or that of their physician That research is coordinated to urgently find a cure LRG Research Has Two Parallel Tracks.:  LRG Research Has Two Parallel Tracks. We conduct our own research using medical updates provided by patients and caregivers We direct a coordinated strategy by the LRG world class research team to find a cure for GIST that will serve as a model for other cancers We conduct our own research using medical updates provided by patients and caregivers:  We conduct our own research using medical updates provided by patients and caregivers LRG’s New Medical Database:  LRG’s New Medical Database Why The Life Raft Group Conducts Its Own Research:  Why The Life Raft Group Conducts Its Own Research Timeliness Patient Relevance Information not available in clinical trials Survival History Of Life Raft Group Research:  History Of Life Raft Group Research Gleevec Resistance: Introduced evaluation of actual dosage as opposed to intended (starting) dosage Evaluated relapse amongst metastatic GIST patients Determined that there was a relationship between dosage and relapse Growing medical data-bases for adult and pediatric GIST History Of Life Raft Group Research:  History Of Life Raft Group Research Gleevec Response Rates: First to report Gleevec Effectiveness for GIST patients Gleevec Side Effects: Designed Severity Rating Scale for Patient Self Evaluation First to report that Side Effects Got Better Over Time First to report Gender Differences in Side Effects The LRG ability to collect patient driven data and publish it on our website and in our newsletters had unintended consequences:  The LRG ability to collect patient driven data and publish it on our website and in our newsletters had unintended consequences Turned the flow of clinical trial information upside down: patient and patient’s doctor get the information first Increased the leverage of the LRG regarding clinical trials Time does not permit a more detailed discussion of the research we conduct using medical updates provided by patients and caregiversInstead I would direct my presentation to::  Time does not permit a more detailed discussion of the research we conduct using medical updates provided by patients and caregivers Instead I would direct my presentation to: We direct a coordinated strategy by the LRG world class research team to find a cure for GIST that will serve as a model for other cancers:  We direct a coordinated strategy by the LRG world class research team to find a cure for GIST that will serve as a model for other cancers We have not made enough progress with the traditional approach to research:  We have not made enough progress with the traditional approach to research Too many are still dying Change in the US Death Rates by Cause, 1950 & 2001:  Change in the US Death Rates by Cause, 1950 andamp; 2001 * Age-adjusted to 2000 US standard population. Sources: 1950 Mortality Data - CDC/NCHS, NVSS, Mortality Revised. 2001 Mortality Data–NVSR-Death Final Data 2001–Volume 52, No. 3. http://www.cdc.gov/nchs/data/nvsr/nvsr52/nvsr52_03.pdf Cerebrovascular Diseases Traditional Research Approach:  Traditional Research Approach Donate money to an institution in the name of research, perhaps with a specific disease designation or General call for proposals from the research community: Individual projects are selected for funding (typical government approach) What’s wrong with the traditional research approach?:  What’s wrong with the traditional research approach? High overhead costs: from 50 to 75% No overall strategic plan; lack of coordination Little accountability Lack of urgency How Does the Life Raft Group Strategy Address the Shortcomings of The Traditional Research Approach?:  How Does the Life Raft Group Strategy Address the Shortcomings of The Traditional Research Approach? We Reduced High Overhead Costs:  We Reduced High Overhead Costs The LRG reduced overhead costs in our research grants from between 50 to 75% down to no more than 10% We Addressed A Lack of Strategy and Coordination :  We Addressed A Lack of Strategy and Coordination We assumed a leadership role We brought together the best scientists in the world We told them that if they created a coordinated strategic plan, and agreed to cooperate, that we would fund it They did We did Our Own Research Team Includes World Class Scientists From:  Our Own Research Team Includes World Class Scientists From Catholic University, Leuven Belgium Cleveland Clinic Dana-Farber Cancer Center/Brigham andamp; Women’s Hospital, Boston Memorial Sloan Kettering Oregon Health Sciences University/VA Hospital Stanford University Our Research Team Members Have Dual Roles :  Our Research Team Members Have Dual Roles To Effectively Implement Their Own Institution’s Research Component of Our Strategic Plan To Coordinate a Priority Research Area Across Institutional and National Boundaries Our Research Team Created A Strategic Plan:  Our Research Team Created A Strategic Plan We committed two year grant awards to implement it We published the plan on our website: www.liferaftgroup.org We Funded Two Tissue BanksTo Support The Search For A Cure:  We Funded Two Tissue Banks To Support The Search For A Cure At Memorial Sloan Kettering for pediatric GIST At Stanford University for adult GIST We Introduced Accountability to the Research Grant Process:  We Introduced Accountability to the Research Grant Process We created six month funding cycles and required a satisfactory progress report to justify further funding We are prepared to shift funds from less promising to more promising areas We introduced a sense of urgency to the search for a cure for GIST:  We introduced a sense of urgency to the search for a cure for GIST We created incentives to reward and accelerate progress by building in accelerated and supplemental funding of promising breakthroughs President Nixon declared war on cancer in 1971, 35 years ago. Our evaluation so far:  Our evaluation so far April 18, 2006 Dear Norman, In the Life Raft Group Research plan of action, one finds both true dedication and conviction that can only emerge from one’s heart as well as efficiency and professionalism… It seems to me that this combination is the best ground for successful research and I would like to express my sincere respect and admiration for your efforts and the efforts of your group. I have no doubt that you will succeed in making a significant contribution to GIST research … Yours truly, Dan Vasella, M.D., CEO, Novartis GIST Is The Perfect Model For Demonstrating How To Cure Other Cancers:  GIST Is The Perfect Model For Demonstrating How To Cure Other Cancers Relatively simple and increasingly understood mechanism of cancer mutations Growing list of targeted drugs to address these mutations Innovative research strategy Unprecedented collaboration between researchers, pharmaceutical companies and patients Patient Roles in Cancer Research Have Evolved:  Patient Roles in Cancer Research Have Evolved Passive Participant Some Input Seat at the Decision Making Table Seat at the Head of the Decision Making Table Food for Thought:  Food for Thought Can we distinguish between acts of outrage that make us feel good and acts of intervention that actually change something ? ThanksFor Listening:  Thanks For Listening The Life Raft Group

Related presentations


Other presentations created by Richie

SFDemographics
05. 09. 2007
0 views

SFDemographics

Greenfield EmergingVoices
05. 09. 2007
0 views

Greenfield EmergingVoices

2006 opinform New
05. 09. 2007
0 views

2006 opinform New

nynofaultauto2
05. 09. 2007
0 views

nynofaultauto2

Cornelius Murphy
05. 09. 2007
0 views

Cornelius Murphy

NYS 2006
05. 09. 2007
0 views

NYS 2006

AboutITEA
05. 09. 2007
0 views

AboutITEA

NDB Monkam 9december2005 anglais
05. 09. 2007
0 views

NDB Monkam 9december2005 anglais

Expanding Universe
27. 08. 2007
0 views

Expanding Universe

NBody
27. 08. 2007
0 views

NBody

NYS TP SlideShow
05. 09. 2007
0 views

NYS TP SlideShow

Youth Retreat02
16. 08. 2007
0 views

Youth Retreat02

2 4 07 Beatitudes
16. 08. 2007
0 views

2 4 07 Beatitudes

salamon nasa program update
27. 08. 2007
0 views

salamon nasa program update

Life of Mark Twain
09. 08. 2007
0 views

Life of Mark Twain

A Day In The Life
09. 08. 2007
0 views

A Day In The Life

Life In Academia
09. 08. 2007
0 views

Life In Academia

als pp
09. 08. 2007
0 views

als pp

bots 4 e marketing
09. 08. 2007
0 views

bots 4 e marketing

Caroline Kovac
09. 08. 2007
0 views

Caroline Kovac

food in later life
09. 08. 2007
0 views

food in later life

argument
05. 09. 2007
0 views

argument

business continuity
09. 08. 2007
0 views

business continuity

Horror2 12 03
27. 08. 2007
0 views

Horror2 12 03

Clay Pots Great Glory
16. 08. 2007
0 views

Clay Pots Great Glory

rhetsit
05. 09. 2007
0 views

rhetsit

ECOL223 4 12
09. 08. 2007
0 views

ECOL223 4 12

Easterlin Slides 09 30 05
09. 08. 2007
0 views

Easterlin Slides 09 30 05

LIDA2007 Pisanski Zumer
27. 08. 2007
0 views

LIDA2007 Pisanski Zumer

ROSE Pres2
16. 08. 2007
0 views

ROSE Pres2

070227 nisimov
16. 06. 2007
0 views

070227 nisimov

04 3
09. 08. 2007
0 views

04 3

LSLR pt5
09. 08. 2007
0 views

LSLR pt5

Lectio Divina YMRM 102007
16. 08. 2007
0 views

Lectio Divina YMRM 102007

Griffiths v3
09. 08. 2007
0 views

Griffiths v3

20010411b
27. 08. 2007
0 views

20010411b

AMC Jesus Story 061020
16. 08. 2007
0 views

AMC Jesus Story 061020

Vitek TechForum Presentation
05. 09. 2007
0 views

Vitek TechForum Presentation

nasc1100 41
27. 08. 2007
0 views

nasc1100 41

Eolss Demo
09. 08. 2007
0 views

Eolss Demo

on demand workspaces granada
09. 08. 2007
0 views

on demand workspaces granada

D2wong humphrey
09. 08. 2007
0 views

D2wong humphrey

mack
27. 08. 2007
0 views

mack

chyba def
09. 08. 2007
0 views

chyba def

042203update
16. 06. 2007
0 views

042203update